Parlodel

This page contains recent news articles, when available, and an overview of Parlodel but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Parlodel
(when available)

Pharmacology and use:
Bromocriptine is an ergoline derivitave dopamine agonist that is used in the treatment of amenorrhea, female infertility, abnormal discharge of breast milk, hypogonadism, Parkinson's disease, and acromegaly. Bromocriptine produces its therapeutic effect in the treatment of Parkinson's disease, a clinical condition characterized by a progressive deficiency in dopamine synthesis in the substantia nigra, by directly stimulating the dopamine receptors in the corpus striatum. For treatment of idiopathic or postencephalitic Parkinson's disease, dysfunctions associated with hyperprolactinemia and in the treatment of acromegaly

Mechanism Of Action:
Bromocriptine acts by directly stimulating the dopamine receptors in the corpus striatum.

News Articles on Bromocriptine

OSHA, NLRB nominees -- no hearings, maybe debate  -  ‎Oct 20, 2009‎
Kassirer and Cecil examined a group of similar cases involving Parlodel, a drug used to stop postpartum lactation. When women in several jurisdictions sued ... Point of Law

Prolattina alta: cause, sintomi e cure  -  ‎Oct 31, 2009‎
Le cure della prolattina alta sono due: il Dostinex (prescrivibile SSN) sicuro ed efficace e il Parlodel. In gravidanza gli alti livelli di prolattina sono ... NanoPress (Blog)

Parlodel.(Drug overview)  -  Jan 22, 2007
Parlodel inhibits the secretion of the hormone prolactin from the pituitary gland. It also mimics the action of dopamine, a chemical lacking in the brain of ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com

Acromegaly - Symptoms, Diagnosis, Treatment of Acromegaly - NY Times …  -  Mar 18, 2008
Octreotide (Sandostatin) or bromocriptine (Parlodel) may control growth hormone release in some people. Pegvisomant (Somavert) directly blocks the effects ... New York Times

Purchase Parlodel No Rx  -  Aug 7, 2007
...requires that all approved drugs fulfill two requirements: 1. The drug must be found to be safe enough Purchase Parlodel No Rx most persons will not hurt ... Sokwanele

From the wrong end of the telescope: a response to professor David …  -  Aug 1, 2006
INTRODUCTION I. FROM THE WRONG END OF THE TELESCOPE A. A Different Perspective on Bendectin B. The Parlodel Saga II. BERNSTEIN'S SLIPPERY SLOPE ARGUMENTS A. ... $4.95 - Michigan Law Review - ECNext

Brand Names/Synonyms:
Parlodel is also known by the following brand names and/or synonymsAlti-Bromocriptine; Apo-Bromocriptine; Bromergocryptine; Bromocriptin; Bromocriptina [Inn-Spanish]; Bromocriptine; Bromocriptine Mesylate; Bromocriptine Methanesulfonate; Bromocriptine [Usan:Ban:Inn]; Bromocriptinum [Inn-Latin]; Bromocryptine; Bromocryptine Mesylate; Bromoergocriptine; Bromoergocryptine; CB 154; CB-154; CCRIS 3244; Parlodel; Parlodel Snaptabs

Drug Category:
Parlodel is categorized under the following by the FDA: Antiparkinson Agents; Antidyskinetics; Unclassified Therapeutic Agents (92:00.00); ATC:G02CB01; ATC:N04BC01

Dosage Forms:
CAPSULE

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
Not Available





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy